have their day. And everybody gets excited about these names, particularly the media people who are thrilled to have something they can pronounce, let alone understand, to talk about.
Join the discussion on
Talk about them all you want. These are sideshows to opportunity. Clorox is really going up because I know a ton of people short it. I had heard it was going to blow the quarter. I can't believe I'm not short it.
Gillette has done some nifty inventory reduction, which is how it grows now. That's hardly viral. But somebody will translate this "value" play into some points.
Count me out. If you want to make some money in the new economy, you can't straddle these two worlds the way you would like to. I have had to cut back on my research on these 32-times-earnings value plays like Gillette and Clorox because the new companies take concentration and brainpower to learn.
I guess I don't have time for Gillette any more. Neither do other managers trying to beat the
. In fact, if you have time for it, how the heck are you going to learn
I know I can't. And I am a maniac.
James J. Cramer is manager of a hedge fund and co-founder of TheStreet.com. At time of publication, his fund was long Be Free and Finisar. His fund often buys and sells securities that are the subject of his columns, both before and after the columns are published, and the positions that his fund takes may change at any time. Under no circumstances does the information in this column represent a recommendation to buy or sell stocks. Cramer's writings provide insights into the dynamics of money management and are not a solicitation for transactions. While he cannot provide investment advice or recommendations, he invites you to comment on his column at